Tag Archives: Sasha Nimmo

Activin B – a potential biomarker for CFS/ME?

Posted on 03/21/2017 by wames

Research abstract: Background: Investigations of activin family proteins as serum biomarkers for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). CFS/ME is a disease with complex, wide-ranging symptoms, featuring persistent fatigue of 6 months or longer, particularly post exertion. No definitive biomarkers are … Continue reading →

Posted in News | Tagged , , , | Comments Off on Activin B – a potential biomarker for CFS/ME?

Severe ME in Australia: suffering ignored and denied help

Posted on 10/26/2016 by wames

ME Australia blog post, by Sasha Nimmo, 13 September 2016: Severe ME: Suffering ignored and denied help Myalgic Encephalomyelitis is estimated to affect between 0.4% and 1% of the population, according to the International Consensus Criteria primer for medical practitioners, endorsed by Australian … Continue reading →

Posted in News | Tagged , , | Comments Off on Severe ME in Australia: suffering ignored and denied help

Metabolomic study finds amino acid deprivation impacts pain in ME/CFS

Posted on 09/02/2016 by wames

ME Australia blog post: Metabolomic study finds amino acid deprivation impacts pain, by Sasha Nimmo, 1 September 2016 A team of Australian scientists looked at biochemistry changes connected with pain and kidney function, identifying the biological basis of the development of widespread pain (July 2016). … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Metabolomic study finds amino acid deprivation impacts pain in ME/CFS

Six year study of abnormal brain changes in ME/CFS

Posted on 07/18/2016 by wames

ME Australia blog post, by  Sasha Nimmo, 12 July 2016: Six year study of abnormal brain changes in chronic fatigue syndrome patients An Australian six year study evaluating progressive brain changes associated with chronic fatigue syndrome (Fukuda and Canadian Consensus … Continue reading →

Posted in News | Tagged , , , , , , | Comments Off on Six year study of abnormal brain changes in ME/CFS